PROFESSIONAL EDITION

The largest community of pharma leaders

Look Who’s On the Move!

      Versantis Appoints Leading Hepatologist Prof Dr Katharina Staufer as Chief Medical Officer

      ZURICH--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for rare liver diseases and rare pediatric diseases, today announced the appointment of Prof Dr...

      Abcuro Appoints Darlene Deptula-Hicks to its Board of Directors

      NEWTON, Mass.--(BUSINESS WIRE)--Abcuro, Inc., a clinical-stage biotechnology company developing therapies for autoimmune diseases and cancer through precise modulation of cytotoxic T and NK cells,...

      Libra Therapeutics Appoints Philip Lambert, Ph.D., as Chief Scientific Officer

      SAN DIEGO--(BUSINESS WIRE)--Libra Therapeutics, Inc. today announced the appointment of Philip Lambert, Ph.D., as the company’s first chief scientific officer. With more than 25...

      Urovant Sciences Announces Leadership Appointments to Drive Future Growth and Geographic Expansion

      IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences, Inc., a wholly-owned subsidiary of Sumitovant Biopharma Ltd., today announced the appointment of Laura Pala Genatossio as...

      Recent Articles